{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Primary+Fibromyalgia&page=2", "query": { "condition": "Primary Fibromyalgia", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Primary+Fibromyalgia&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-10T13:15:30.446Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00115804", "title": "Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Juvenile Primary Fibromyalgia Syndrome (JPFS)", "Fibromyalgia" ], "interventions": [ { "name": "Fluoxetine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "13 Years to 18 Years" }, "enrollment_count": 6, "start_date": "2005-06", "completion_date": "2011-02", "has_results": true, "last_update_posted_date": "2017-02-10", "last_synced_at": "2026-06-10T13:15:30.446Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00115804" }, { "nct_id": "NCT05068791", "title": "Psilocybin-facilitated Treatment for Chronic Pain", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Fibromyalgia, Primary" ], "interventions": [ { "name": "Psilocybin", "type": "DRUG" }, { "name": "Dextromethorphan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "25 Years to 65 Years · Female only" }, "enrollment_count": 30, "start_date": "2023-11-01", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-03-11", "last_synced_at": "2026-06-10T13:15:30.446Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT05068791" }, { "nct_id": "NCT01697254", "title": "The CARRA Registry", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Juvenile Idiopathic Arthritis", "Systemic Lupus Erythematosus", "Mixed Connective Tissue Disease", "Juvenile Ankylosing Spondylitis", "Juvenile Dermatomyositis", "Localized Scleroderma", "Systemic Sclerosis", "Vasculitis", "Sarcoid", "Fibromyalgia, Primary", "Auto-inflammatory Disease", "Idiopathic Uveitis Idiopathic" ], "interventions": [], "intervention_types": [], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 9587, "start_date": "2009-08", "completion_date": "2015-10", "has_results": false, "last_update_posted_date": "2015-11-17", "last_synced_at": "2026-06-10T13:15:30.446Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01697254" }, { "nct_id": "NCT01020474", "title": "Adolescent Fibromyalgia Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "placebo", "type": "DRUG" }, { "name": "pregabalin (Lyrica)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 107, "start_date": "2010-05", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2021-01-28", "last_synced_at": "2026-06-10T13:15:30.446Z", "location_count": 30, "location_summary": "Los Angeles, California • Santa Ana, California • Delray Beach, Florida + 18 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Delray Beach", "state": "Florida" }, { "city": "Delray Beach", "state": "Florida" }, { "city": "Delray Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01020474" }, { "nct_id": "NCT01291758", "title": "Exercise in Gulf War Illness (GWI)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Gulf War Illness", "Persian Gulf Syndrome" ], "interventions": [ { "name": "Submaximal bicycle exercise stress tests performed 24 hr apart", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Georgetown University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "38 Years", "maximum_age": "86 Years", "sex": "ALL", "summary": "38 Years to 86 Years" }, "enrollment_count": 50, "start_date": "2009-07", "completion_date": "2012-09", "has_results": false, "last_update_posted_date": "2019-08-06", "last_synced_at": "2026-06-10T13:15:30.446Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01291758" }, { "nct_id": "NCT03674541", "title": "The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome", "Chronic Fatigue Syndrome", "Myalgic Encephalomyelitis", "Exercise Intolerance", "Dysautonomia", "Low Ventricular Filling Pressures (Preload Failure)", "Postural Orthostatic Tachycardia Syndrome", "Orthostatic Hypotension", "Fibromyalgia" ], "interventions": [ { "name": "Pyridostigmine Bromide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 45, "start_date": "2020-01-14", "completion_date": "2021-12-20", "has_results": true, "last_update_posted_date": "2022-11-08", "last_synced_at": "2026-06-10T13:15:30.446Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03674541" }, { "nct_id": "NCT01328002", "title": "Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Primary Fibromyalgia" ], "interventions": [ { "name": "Milnacipran", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "13 Years to 17 Years" }, "enrollment_count": 116, "start_date": "2011-04-30", "completion_date": "2012-08-31", "has_results": true, "last_update_posted_date": "2019-05-14", "last_synced_at": "2026-06-10T13:15:30.446Z", "location_count": 47, "location_summary": "Birmingham, Alabama • Bullhead City, Arizona • Fresno, California + 38 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Bullhead City", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01328002" }, { "nct_id": "NCT02015234", "title": "12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Primary Fibromyalgia" ], "interventions": [ { "name": "TNX-102 SL", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tonix Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 158, "start_date": "2013-12", "completion_date": "2015-08", "has_results": true, "last_update_posted_date": "2017-07-07", "last_synced_at": "2026-06-10T13:15:30.446Z", "location_count": 13, "location_summary": "Denver, Colorado • Brooksville, Florida • Orlando, Florida + 10 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Brooksville", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Frederick", "state": "Maryland" }, { "city": "North Dartmouth", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02015234" }, { "nct_id": "NCT04806620", "title": "Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Post-Acute COVID-19 Syndrome", "ME/CFS", "Rheumatic Arthritis", "Juvenile Rheumatoid Arthritis (JRA)", "Psoriatic Arthritis (PsA)", "Ankylosing Spondylitis (AS)", "Autoimmune Encephalitis", "Celiac Disease", "Celiac Disease in Children", "Chronic Lyme Disease", "Post-treatment Lyme Disease Syndrome", "Crohn's Disease", "Dysautonomia", "Anorexia Nervosa", "Bulimia Nervosa", "ARFID", "Avoidant / Restrictive Food Intake Disorder", "Ehlers Danlos Syndrome", "Endometriosis", "Fibromyalgia (FM)", "Long COVID", "Lupus", "Migraines", "Mast Cell Activation Syndrome", "Multiple Sclerosis", "Myalgic Encephalomyelitis (ME)", "Myasthenia Gravis, Generalized", "Myasthenia Gravis in Children", "Narcolepsy", "Obsessive Compulsive Disorder (OCD)", "PANDAS", "Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)", "POTS - Postural Orthostatic Tachycardia Syndrome", "General Anxiety Disorder, Social Anxiety Disorder", "PTSD - Post Traumatic Stress Disorder", "Psoriasis", "Traumatic Brain Injury", "Tourette's Syndrome", "Inflammatory Bowel Disease (IBD)", "Autoimmune Diseases", "Neurological Diseases or Conditions", "Psychiatric Disorder", "Sjogren's Syndrome", "Ulcerative Colitis and Crohn's Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Brain Inflammation Collaborative", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 10000, "start_date": "2023-07-05", "completion_date": "2030-12-31", "has_results": false, "last_update_posted_date": "2026-01-22", "last_synced_at": "2026-06-10T13:15:30.446Z", "location_count": 1, "location_summary": "Delafield, Wisconsin", "locations": [ { "city": "Delafield", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04806620" }, { "nct_id": "NCT03911609", "title": "Cardiovascular Autonomic Function and Endogenous Pain Modulation", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Fibromyalgia", "Exercise", "Pain", "Autonomic Dysfunction", "Physical Activity" ], "interventions": [ { "name": "Exercise", "type": "OTHER" }, { "name": "Cognitive Task", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Marquette University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 250, "start_date": "2019-03-20", "completion_date": "2022-12-30", "has_results": false, "last_update_posted_date": "2019-04-11", "last_synced_at": "2026-06-10T13:15:30.446Z", "location_count": 1, "location_summary": "Milwaukee, Wisconsin", "locations": [ { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT03911609" } ] }